Skip to main content

Pharmacotherapy of Schizophrenia in Childhood and Adolescence

  • Conference paper
Schizophrenia and Youth

Abstract

Schizophrenic psychoses represent the main indication for psychopharmacotherapy. Foremost among the drugs with antipsychotic effects are the neuroleptics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alanen YO, Räkköläinen V, Laakso J (1982) Krankheitsmodelle bei der Schizophrenie und die Bedürfnisangemessenheit der Behandlung. Nervenarzt 53: 150–153

    PubMed  CAS  Google Scholar 

  • Alfredsson G, Bjerkenstedt L, Edman G, Härnryd C, Oxenstierna G, Sedvall G, Wiesel FA (1984) Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine. Acta Psychiatr Scand 69: 49–74

    Article  Google Scholar 

  • Baldessarini RJ, Davis JM (1980) What is the best maintenance dose of neuroleptics in schizophrenia? Psychiatr Res 3: 115–122

    Article  CAS  Google Scholar 

  • Baldessarini RJ, Cohen BM, Teicher MH (1988) Significance of neuroleptic dose and plasma level in the pharmacologie treatment of psychoses. Arch Gen Psychiatry 45: 79–91

    Article  PubMed  CAS  Google Scholar 

  • Benedetti G (1987) Wahn und Halluzination in psychiatrischer Sicht. In: Olbrich HM (ed) Halluzination und Wahn. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Bigelow LB, Kirch DG, Braun T, Korpi ED, Wagner RL, Zalcman S, Wyatt RJ (1985) Absence of relationship of serum haloperidol concentration and clinical response in chronic schizophrenia: a fixed-dose study. Psychopharmacol Bull 21: 66–68

    PubMed  CAS  Google Scholar 

  • Campbell M, Grega DM, Green WH, Bennet WG (1983) Neuroleptic-induced dyskinesias in children. Clin Neuropharmacol 6: 207–222

    Article  PubMed  CAS  Google Scholar 

  • Cohen BM (1988) Neuroleptic drugs in the treatment of acute psychoses: how much do we really know? Psychopharmacol Ser 5: 47–61

    Article  PubMed  CAS  Google Scholar 

  • Crow TJ (1980) Molecular pathology of schizophrenia: more than one dimension of pathology? Br Med J 280: 66–68

    Article  PubMed  CAS  Google Scholar 

  • Dalery J, Maillet J, de Villard R (1985) Traitment de dix-sept adolescents psychotiques par le dogmatil. Sem Hôp Paris 61: 1327–1330

    Google Scholar 

  • Davis JM, Schaffer CB, Kilian GA, Kinard C, Chan C (1980) Important issues in the drug treatment of schizophrenia. Schizophr Bull 6: 70–87

    Article  PubMed  CAS  Google Scholar 

  • Denber HCB, Bente D, Rajotte P (1962) Comparative analysis of the action of butyrylperazine at Manhattan State Hospital and the University Psychiatric Clinic at Erlangen. Am J Psychiatry 119: 203–206

    PubMed  CAS  Google Scholar 

  • Eggers C (1973) Verlaufsweisen kindlicher und präpuberaler Schizophrenien. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Eggers C (1975) Nichtdelirante Intoxikationspsychosen im Kindesalter. Z Kinderheilkd 119: 71–86

    Article  PubMed  CAS  Google Scholar 

  • Eggers C (1984) Rezeptorverhalten der Psychopharmaka. In: Nissen G, Eggers C, Martinius J Kinder- und jugendpsychiatrische Pharmakotherapie in Klinik und Praxis. Springer, Berlin Heidelberg New York, pp 15–29

    Google Scholar 

  • Farde L, Wiesel FA, Halldin C, Sedvall G (1988) Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45: 71–76

    Article  PubMed  CAS  Google Scholar 

  • Gerlach J, Behnke K, Heltberg J, Munk-Andersen E, Nilsen H (1985) Sulpiride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effects, side effects and plasma concentrations. Br J Psychiatry 147: 283–288

    Article  PubMed  CAS  Google Scholar 

  • Gualtieri CT, Barnhill J, McGimsey J, Schell D (1980) Tardive dyskinesia and other movement disorders in children treated with psychotropic drugs. J Am Acad Child Psychiatry 19: 491–510

    Article  PubMed  CAS  Google Scholar 

  • Marder SR, van Putten T, Mintz J, McKenzie J, Lebell M, Faltico G, May PRA (1984) Costs and benefits of two doses of fluphenazine. Arch Gen Psychiatry 41: 1025–1029

    Article  PubMed  CAS  Google Scholar 

  • Marder SR, van Putten T, Mintz J (1987) Low and conventional dose maintenance therapy with fluphenazine decanoate: two year outcome. Arch Gen Psychiatry 44: 518–521

    Article  PubMed  CAS  Google Scholar 

  • Mc Andrew JB, Case Q, Treffert DA (1972) Effects of prolonged phenothiazine intake on psychotic and other hospitalized children. J Autism Child Schizophr 2: 75–91

    Article  Google Scholar 

  • Müller WE (1989) Neuroleptika. Die Dopamin-Hypothese im neuen Gewand. Dtsch Apoth Z 129: 799–806

    Google Scholar 

  • Polizos R, Engelhardt DM (1978) Dyskinetic phenomena in children treated with psychotropic medications. Psychopharmacol Bull 14: 65–68

    PubMed  CAS  Google Scholar 

  • Sedvall G, Farde L, Persson A, Wiesel FA (1986) Imaging of neurotransmitter receptors in the living human brain. Arch Gen Psychiatry 43: 995–1005

    Article  PubMed  CAS  Google Scholar 

  • Uschakov GK (1965) Clinique de la schizophrénie. Psychiatr Enfant 8: 1–48

    Google Scholar 

  • Waddington JL (1989) Sight and insight: brain dopamine receptor occupancy by neuroleptics visualised in living schizophrenic patients by positron emission tomography. Br J Psychiatry 154: 433–436

    Article  PubMed  CAS  Google Scholar 

  • Woggon B (1987) Dosierung von Neuroleptika. In: Pichot P, Möller HJ (eds) Tropon Symposium, vol. 2. Springer, Berlin Heidelberg New York, pp 81–91

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Eggers, C., Röpke, B. (1991). Pharmacotherapy of Schizophrenia in Childhood and Adolescence. In: Eggers, C. (eds) Schizophrenia and Youth. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-02684-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-02684-7_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-52485-4

  • Online ISBN: 978-3-662-02684-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics